This latest delivery is particularly important as Rwanda witnesses a growing number of COVID-19 cases.
COVAX is a global coalition that works to ensure fair and equitable access to COVID-19 vaccines around the world.
The World Health Organization (WHO) had so listed the COVID-19 vaccine developed by the Sinopharm's BBIBP-CorV vaccine, the Pfizer/BioNTech, two versions of the AstraZeneca/Oxford vaccine, the Janssen vaccine and the Moderna vaccine for emergency use.
Rwanda has registered 26,963 cases with 353 deaths as the first wave of COVID-19 hit the country in March last year.
A total of 299,400 people have so far received the first jabs of the AstraZeneca vaccine, while 51,000 have received Pfizer jabs, according to Rwanda's Health ministry.
The Pfizer vaccine was mainly administered in Kigali as it needs to be stored in special freezers at minus 70 C (minus 94 F).